齐拉西酮联合康复性心理治疗在精神分裂症中的疗效分析  

Ziprasidone combined with rehabilitation therapy in schizophrenic patients

作　　者：周立发[1] 

机构地区：[1]山东省青州荣军医院,262500

出　　处：《中国实用医药》2013年第10期14-15,共2页China Practical Medicine

摘　　要：目的探讨齐拉西酮联合康复性心理治疗在精神分裂症患者中的应用意义及疗效分析。方法将100例精神分裂症患者随机分为对照组50例(单纯齐拉西酮治疗)、观察组50例(齐拉西酮联合康复性心理治疗),对照两组患者治疗不同阶段的BPRS、自知力的评分及疗效。结果两组患者治疗后BPRS及自知力的评分比较(t=5.21、5.66,P<0.05,具有显著性差异),两组治疗后疗效比较(χ2=5.33、5.22、4.87、5.55、4.66,P<0.05,具有显著性差异)。结论齐拉西酮联合康复性心理治疗应用在精神分裂症患者中可明显增加疗效,提高患者的自知力,减轻患者家庭及社会的负担,值得临床推广。Objective To investigate the ziprasidone combined with rehabilitation therapy in schizo- phrenia application significance and effect analysis of patients with dementia. Methods 100 patients with schizophrenia were randomly divided into two groups ： 50 cases of the control group （ simple ziprasidone treat- ment）, 50 cases in observation group （ziprasidone combined with rehabilitation therapy）, control scores and ef- ficacy in different stages of treatment group two patients. Results The BPRS insight. Comparison of the results of two groups of patients after the treatment of BPRS and the insight scores （ t = 5.21, 5.66, P 〈 0. 05, with significant difference）, compared the efficacy between two groups after treatment （x2 = 5.33, 5.22, 4. 87, 5.55,4. 66, P 〈 0. 05, with significant difference）. Conclusion Ziprasidone combined with rehabilitation therapy in patients with schizophrenia can significantly increase the efficacy, improve the patient＇s family and social insight, reduce the burden of patients, is worthy of clinical application.

关 键 词：齐拉西酮 心理治疗 精神分裂症 

分 类 号：R749.3[医药卫生—神经病学与精神病学]